Notice ID: 5638f6e61f4442d28dd36c7811458dddSolicitation
Quetiapine Fumarate XR Tablets
Responses closed . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM EDT
- Posted
- May 2, 2023
- Notice type
- Solicitation
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of WarDEFENSE LOGISTICS AGENCY
Notice details
- Office
- DLA TROOP SUPPORT
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- SPE2D223R0010
- Notice ID
- 5638f6e61f4442d28dd36c7811458ddd
Description
Amendment 0003 SPE2D2-23-R-0010 issued May 2, 2023 to extend the closing date from May 5, 2023 3:00 PM EDT to May 19, 2023 3:00 PM EDT. Amendment 0002 SPE2D2-23-R-0010 issued April 18, 2023 to extend the closing date from April 21, 2023 3:00 PM EDT to May 5, 2023 3:00 PM EDT. Amendment 0001 SPE2D2-23-R-0010 issued April 12, 2023 to change the size standard for NAICS code from 1250 to 1300 on page 1, block 10 of the Standard Form 1449. Quetiapine Fumarate XR - SPE2D2-23-R-0010 - Solicitation
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (4)
- Download
Amendment 0003 SPE2D2-23-R-0010.pdf
333 KBAdded in Solicitation version 5Posted - Download
Amendment 0002 SPE2D2-23-R-0010.pdf
18 KBAdded in Solicitation version 4Posted - Download
Amendment 0001 SPE2D2-23-R-0010.pdf
323 KBAdded in Solicitation version 3Posted - Download
Quetiapine Fumarate XR Tablets National Contract Solicitation SPE2D223R0010.pdf
1.4 MBAdded in Solicitation version 2Posted
Lifecycle
- 1Version 1Presolicitation
Quetiapine Fumarate XR Tablets
- 2Version 2Solicitation
Type changed from Presolicitation to Solicitation
Quetiapine Fumarate XR Tablets
- 3Version 3Solicitation
Quetiapine Fumarate XR Tablets
- 4Version 4Solicitation
Quetiapine Fumarate XR Tablets
- 5Version 5SolicitationCurrent
Quetiapine Fumarate XR Tablets
- 6Version 6Award Notice
Type changed from Solicitation to Award Notice
Quetiapine Fumarate XR Tablets
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The Defense Logistics Agency is issuing a solicitation for a national requirements contract for Epinephrine Injectors. Procurement details follow. Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current solicitation date is October of 2026. | - | Solicitation | 11/30/2026 |
The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Fentanyl Citrate Injection Solution. Procurement details follow. Fentanyl (PF) 50 MCG/ML Injection Solution in 1 ML, 2 ML, 5 ML,10 ML, 20 ML and 50 ML in Vials or Ampules, Pack Size of 1, 2, 5, 10, 20, and 50. Competition will be restricted to domestic sources (vendors providing Active Pharmaceutical Ingredients (API) and Final Dosage Forms (FDF) manufactured domestically), the procurement will be competed among all qualified domestic manufacturers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War (DoW), Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Nancy Fernandez at (445) 737-0731 or Nancy.Fernandedz@dla.mil with any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is November/December of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date. | - | Pre-Solicitation | Open |
This RFI does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to this announcement. Item 0001: OXYGEN, USP, FILLED CYLINDER, SIZE D, 95GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-132-5181 Shall be made in accordance with MIL-O-37997 DATED 18 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. Item 0002: OXYGEN, USP, FILLED CYLINDER, SIZE H, 1650 GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-132-5199 Shall be made in accordance with MIL-O-37997 DATED 18 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. Item 0003: NITROUS OXIDE, USP, FILLED CYLINDER, SIZE D, 250 GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-130-1920 Shall be made in accordance with MIL-N-37996 DATED 24 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. ----------------------------------------------------- The Defense Logistics Agency Troop Support is seeking sources capable of providing the Medical Gas Cylinder in accordance with the Military Specifications listed above. NOTE: Only Type I-DOT 3AA STEEL Medical Gas Cylinders are acceptable. If your firm currently manufactures or distributes Type I-DOT 3AA STEEL Medical Gas Cylinders in accordance with the Military Specifications and changes attached, please provide information with respect to the following: Source and Part Number being supplied for each type of cylinder Place of manufacture for each type of cylinder Source for the Medical Gases Current unit sale price for each type of cylinder prefilled with the medical grade gas Estimated annual capacity for each type of cylinder/medical grade gas Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for the ATNAA. All information submitted shall remain with the U.S. Government and will not be returned. It will be kept confidential as allowed by relevant Federal law and will be eligible for additional special protections under the conditions of the Protected Critical Infrastructure Information (PCII) Program outlined in the Critical Infrastructure Information Act of 2002. Your response to this RFI may be submitted electronically via emailed to Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil | - | Market Research | 11/15/2026 |
Please see attached for the sources sought notice/market research survey and MPID. | - | Market Research | 11/30/2026 |
Modification to add clause. | - | Awarded | Open |
Additional Details
Solicitation Number
SPE2D223R0010
Archive Date
May 19, 2029
Office Address
PHILADELPHIA, PA, 19111